|
Market Closed -
Other stock markets
|
Pre-market 08:33:11 am | |||
| 278.32 USD | +0.08% |
|
277.24 | -0.39% |
| Dec. 03 | Sector Update: Health Care Stocks Decline Premarket Tuesday | MT |
| Dec. 03 | Sector Update: Health Care | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 150B 142B 133B 118B 210B 12,673B 231B 1,648B 611B 5,197B 562B 550B 22,369B | P/E ratio 2024 * |
30.8x | P/E ratio 2025 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise value | 198B 188B 175B 156B 279B 16,776B 306B 2,182B 809B 6,879B 744B 727B 29,610B | EV / Sales 2024 * |
5.97x | EV / Sales 2025 * | 5.63x |
| Free-Float |
99.75% | Yield 2024 * |
3.26% | Yield 2025 * | 3.49% |
More valuation ratios
* Estimated data
More news
Last Transcript: Amgen Inc.
More recommendations
More press releases
More news
| 1 day | +0.08% | ||
| 1 week | -0.60% | ||
| Current month | -1.61% | ||
| 1 month | -12.81% | ||
| 3 months | -15.79% | ||
| 6 months | -9.47% | ||
| Current year | -3.37% |
1 week
276.50
283.64
1 month
257.80328.25
Current year
257.80346.85
1 year
257.80346.85
3 years
205.97346.85
5 years
177.05346.85
10 years
130.09346.85
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 61 | 2012-04-30 |
Peter Griffith
DFI | Director of Finance/CFO | 65 | 2019-12-31 |
David Reese
CTO | Chief Tech/Sci/R&D Officer | 61 | 2018-07-25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 61 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 63 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 69 | 2002-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.84% | 0 M€ | 0.00% | - | |
| 7.63% | 0 M€ | 0.00% | - | |
| 5.08% | 139 M€ | +25.81% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.08% | -0.60% | +2.15% | +37.48% | 150B | ||
| +1.69% | +3.04% | +39.26% | +231.19% | 732B | ||
| +0.84% | +3.10% | +11.97% | +122.15% | 488B | ||
| -1.58% | -1.40% | -3.80% | -4.40% | 367B | ||
| -0.15% | +0.20% | +26.56% | +52.71% | 321B | ||
| +1.23% | +0.23% | -1.56% | +38.87% | 258B | ||
| -0.66% | +1.23% | +6.22% | -29.74% | 231B | ||
| -0.13% | +1.19% | +8.95% | +26.44% | 210B | ||
| +2.24% | +2.84% | +5.81% | +31.73% | 212B | ||
| -1.01% | -0.81% | -11.59% | -52.90% | 145B | ||
| Average | +0.36% | +0.42% | +8.40% | +45.35% | 311.19B | |
| Weighted average by Cap. | +0.30% | +1.14% | +14.30% | +82.76% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 33.17B 31.56B 29.4B 26.2B 46.67B 2,810B 51.23B 365B 136B 1,152B 125B 122B 4,960B | 34.28B 32.61B 30.38B 27.08B 48.23B 2,904B 52.94B 378B 140B 1,191B 129B 126B 5,126B |
| Net income | 4.88B 4.64B 4.33B 3.86B 6.87B 414B 7.54B 53.79B 19.94B 170B 18.35B 17.94B 730B | 6.15B 5.85B 5.45B 4.86B 8.65B 521B 9.5B 67.76B 25.12B 214B 23.11B 22.59B 920B |
| Net Debt | 48.43B 46.07B 42.91B 38.25B 68.13B 4,102B 74.79B 534B 198B 1,682B 182B 178B 7,241B | 43.38B 41.26B 38.44B 34.26B 61.02B 3,674B 66.99B 478B 177B 1,507B 163B 159B 6,485B |
More financial data
* Estimated data
Employees
26,700
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-03 | 278.32 $ | +0.08% | 5,468,847 |
| 24-12-02 | 278.10 $ | -1.69% | 4,677,815 |
| 24-11-29 | 282.87 $ | +1.00% | 2,232,846 |
| 24-11-27 | 280.07 $ | +0.02% | 6,622,764 |
| 24-11-26 | 280.01 $ | -4.76% | 17,010,332 |
Delayed Quote Nasdaq, December 03, 2024 at 04:00 pm EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
278.32USD
Average target price
328.39USD
Spread / Average Target
+17.99%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AMGN Stock